The fact that circulating histones correlate negatively with APC in SS cases revives the notion of reintroducing into the market the withdrawn recombinant human APC or analogues, with the aim of providing a new battery of therapeutic strategies designed to combat sepsis and its associated morbidity and mortality. The gene discussed is APC; the disease is Sepsis.